Assertio therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Assertio therapeutics Contact Number

Assertio Therapeutics » Contact Us

4 hours ago Assertiotx.com Show details

224.419.7106

Contact Us 100 South Saunders Road, Suite 300 Lake Forest, IL 60045 Tel: 224.419.7106 Fax: 510.744.8001

Category: Contact SupportShow more

Assertio Therapeutics

7 hours ago Assertiotx.com Show details

224.419.7106

Contact Us 100 South Saunders Road, Suite 300 Lake Forest, IL 60045 Tel: 224.419.7106 Fax: 510.744.8001

Category: Contact NumberShow more

Assertio Therapeutics » Compliance & Ethics

5 hours ago Assertiotx.com Show details

866.458.6389

1. Assertio has implemented procedures which allow product complaints and adverse event information to be reported to the company. This may include information regarding an adverse event experienced by a patient who is currently using, or who recently used, an Assertio product. The procedures in place allow product complaints and adverse event reports to be documented and handled in accordance with applicable laws and regulations. Directors and employees who become aware of an adverse event or product complaint must report it by calling 1.866.458.6389 within one (1) business day of becoming aware of the potential adverse event or product complaint.

Category: Contact NumberShow more

SPRIX® Get In Touch

1 hours ago Sprix.com Show details

866-458-6389

To report SUSPECTED ADVERSE REACTIONS, contact Assertio Therapeutics, Inc. at 866-458-6389 or FDA at 1-800-FDA-1088 or ww.fda.gov/medwatch. Indications and Usage SPRIX ® (ketorolac tromethamine) is indicated in adult patients for the short term (up to 5 days) management of moderate to moderately severe pain that requires analgesia at the

Category: Contact NumberShow more

Assertio Crunchbase Company Profile & Funding

7 hours ago Crunchbase.com Show details

Legal Name Assertio Therapeutics, Inc. Stock Symbol NASDAQ:ASRT. Company Type For Profit. Contact Email [email protected] Phone Number 5107448001. Assertio is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. The company was founded in 1995 and

Founder: John W. Shell
Location: Newark, California
Founded: Jul 01, 2007

Category: Contact NumberShow more

Assertio Therapeutics » Marketed Products

7 hours ago Assertiotx.com Show details

866-458-6389

To report SUSPECTED ADVERSE REACTIONS, contact Assertio Therapeutics, Inc. at 866-458-6389 or FDA at 1-800-FDA-1088 or

Category: Contact NumberShow more

Arthur Higgins President & Chief Executive Officer

Just Now Open.winmo.com Show details

Verified contact information for Arthur Higgins - President & Chief Executive Officer, Assertio Therapeutics, Inc. including email address, phone number and personality insights that will make your sales and marketing efforts much more effective.

Email: a*******@**********.com
Location: 100 South Saunders Road, Lake Forest, 60045, IL

Category: Contact NumberShow more

Assertio Therapeutics Crunchbase Company Profile & …

1 hours ago Crunchbase.com Show details

Assertio reflects an aspirational mindset that is forward thinking, energetic, and entrepreneurial in spirit.

Category: Contact NumberShow more

Assertio Overview, News & Competitors ZoomInfo.com

2 hours ago Zoominfo.com Show details

Assertio Holdings, Inc. to Report Second Quarter 2021 Financial Results After the Close of Markets on Thursday, August 5, 2021 LAKE FOREST, Ill., July 20, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release second quarter 2021 financial results on Thursday, August 5, 2021, after the close of markets.

Category: Contact NumberShow more

Assertio Therapeutics Inc ZIP 60045, NAICS 325412

4 hours ago Siccode.com Show details

"Assertio Therapeutics Inc" of Lake Forest, IL 60045 operates primarily in SIC Code 2834 - Pharmaceutical Preparations and NAICS Code 325412 - Pharmaceutical Preparation Manufacturing. Assertio Therapeutics Inc is a medium-sized business with …

Category: Contact NumberShow more

Assertio LinkedIn

8 hours ago Linkedin.com Show details

Vice President, Quality Assurance at Assertio Therapeutics, Inc. See all employees Updates Assertio 7,304 followers. 2mo Report this post Assertio

Category: Contact NumberShow more

Assertio Therapeutics » Privacy Policy

2 hours ago Assertiotx.com Show details

224.419.7106

Contact Us 100 South Saunders Road, Suite 300 Lake Forest, IL 60045 Tel: 224.419.7106 Fax: 510.744.8001

Category: Contact NumberShow more

Assertio Therapeutics, Inc. (ASRT) Company Profile

6 hours ago Stockanalysis.com Show details

Company profile for Assertio Therapeutics, Inc. (ASRT) with a description, list of executives, contact details and other key facts. Company profile for Assertio Therapeutics, Inc. (ASRT) with a description, list of executives, contact details and other key facts. CUSIP Number: 04545L107: ISIN Number: US04546C2052: Employer ID: 94-3229046

Category: Contact NumberShow more

Assertio Therapeutics Inc Profile GetCompanyInfo

5 hours ago Getcompanyinfo.com Show details

About Assertio Therapeutics Inc. Assertio Therapeutics Inc was incorporated in 1995 and is located in Lake Forest, United States. The company specialises in Neurology, Orphan & Specialty Medicines, Gabapentin Tablets, Oral Solution, Liquid Filled Capsules, Diclofenac Potassium, Diagnosis of Adrenal Insufficiency, Acute Migraine Attacks with an estimated revenue and employee in the range of $50

Category: Contact NumberShow more

SEC Filing Assertio Therapeutics, Inc.

7 hours ago Investor.assertiotx.com Show details

ASSERTIO THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware. 001-13111. 94-3229046 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 100 S. Saunders Road, Suite 300, Lake Forest, IL 60045 (Address of principal executive offices, with zip code

Category: Contact NumberShow more

ASRT Assertio Holdings Inc. • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Show details

LAKE FOREST, Ill., July 20, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ:ASRT) today announced that it will release second quarter 2021 financial results on Thursday, August 5, 2021, after the close of markets.Following the release of its financial results, Assertio's management will host a conference call beginning at 4:30 p.m. eastern time.

Category: Contact NumberShow more

SEC Filing Assertio Therapeutics, Inc.

7 hours ago Investor.assertiotx.com Show details

Assertio Therapeutics, Inc. (Assertio or the Company) is a leading diversified, specialty pharmaceutical company focused on distinctive products that offer enhanced therapeutic options for patients in need, while maintaining the highest ethical standards in all our business practices. with a limited number of holders of Assertio’s 2.50%

Category: Contact NumberShow more

Assertio Therapeutics Wikipedia

1 hours ago En.wikipedia.org Show details

Number of employees. 116 (2019) Website. www .assertiotx .com. Assertio Therapeutics, Inc. (formerly Depomed, Inc.) is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California.

Category: Contact NumberShow more

Assertio Therapeutics, Inc. in Salt Lake City, UT

9 hours ago Bizapedia.com Show details

Assertio Therapeutics, Inc. is an Utah Corporation - Foreign - Profit filed On September 7, 2018. The company's filing status is listed as Active and its File Number is 10979214-0143. The Registered Agent on file for this company is Corporation Service Company and is located at 15 West South Temple Ste 1701, Salt Lake City, UT 84101.

Location: IL

Category: Contact NumberShow more

SEC Filing Assertio Therapeutics, Inc.

7 hours ago Investor.assertiotx.com Show details

He also serves as a board observer of MedRhythms, Inc. and as a director of Vinci Therapeutics, all privately held. From 2014 to June 2020, Mr. McKee served as a director and member of the audit and compensation committees of Agile Therapeutics, Inc., a publicly-held …

Category: Contact NumberShow more

Assertio Holdings, Inc. to Report Second Quarter 2021

5 hours ago Investor.assertiotx.com Show details

LAKE FOREST, Ill., July 20, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release second quarter 2021 financial results on Thursday, August 5, 2021, after the close of markets.Following the release of its financial results, Assertio’s management will host a conference call beginning at 4:30 p.m. eastern time.

Category: Contact NumberShow more

ASSERTIO HOLDINGS, INC. AS ACQUIROR OF ASSERTIO

3 hours ago S28.q4cdn.com Show details

224-419-7106

1 Issuer's name 2 Issuer's employer identification number (EIN) 3 Name of contact for additional information 4 Telephone No. of contact 5 Email address of contact ASSERTIO HOLDINGS, INC. AS ACQUIROR OF ASSERTIO THERAPEUTICS & ZYLA 85-0598378 DAN PEISERT 224-419-7106 [email protected] 100 S SAUNDERS ROAD, SUITE 300 LAKE …

Category: Contact NumberShow more

Assertio Therapeutics, Inc. Company Profile Lake Forest

9 hours ago Dnb.com Show details

Find company research, competitor information, contact details & financial data for Assertio Therapeutics, Inc. of Lake Forest, IL. Get the latest business insights from Dun & Bradstreet.

Category: Contact NumberShow more

Assertio Reports First Quarter 2021 Financial Results

Just Now Investor.assertiotx.com Show details

Investor Contact Max Nemmers Head, Investor Relations and Administration [email protected] Forward Looking Statements. Statements in this communication that are not historical facts are forward-looking statements that reflect Assertio's current expectations, assumptions and estimates of future performance and economic conditions. These

Category: Contact NumberShow more

Zyla Life Sciences Crunchbase Company Profile & Funding

8 hours ago Crunchbase.com Show details

800-518-1084

Life Science. Headquarters Regions Greater Philadelphia Area, Great Lakes, Northeastern US. Operating Status Active. Company Type For Profit. Contact Email [email protected] Phone Number 1-800-518-1084. Zyla Life Sciences is a business committed to bringing important products to patients and healthcare providers.

Category: Contact NumberShow more

Assertio Reports Second Quarter 2021 Financial Results

2 hours ago Investor.assertiotx.com Show details

Investor Contact. Max Nemmers Head, Investor Relations and Administration [email protected] Forward Looking Statements. Statements in this communication that are not historical facts are forward-looking statements that reflect Assertio's current expectations, assumptions and estimates of future performance and economic conditions. These

Category: Contact NumberShow more

Events & Presentations Assertio Therapeutics, Inc.

6 hours ago Investor.assertiotx.com Show details

The following is a list of the conferences that Assertio is scheduled to attend as well as upcoming corporate events, including quarterly earnings conference calls. Presentations. Aug 05, 2021. Q2 2021 Assertio Therapeutics Earnings Presentation. 802.5 KB.

Category: Contact NumberShow more

Contact Us Astellas Gene Therapies Therapeutics

9 hours ago Astellasgenetherapies.com Show details

(415) 818-1005

Astellas Gene Therapies. 600 California Street, 17th Floor San Francisco, CA 94108 (415) 818-1005

Category: Contact SupportShow more

Assertio Holdings Number of Employees 20062021 ASRT

4 hours ago Macrotrends.net Show details

Assertio Holdings number of employees from 2006 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Assertio Holdings Inc. is a specialty pharmaceutical company.

Category: Contact NumberShow more

ASRT Short Interest Assertio Holdings Inc Short

8 hours ago Fintel.io Show details

ASRT / Assertio Holdings Inc short sale volume is shown in the following chart. Short Sale volume shows the number of trades marked as short sales in various trading venues. For more information on how to interpret this data, read this information notice provided by FINRA.

Category: Contact NumberShow more

ENVEDA THERAPEUTICS INDIA PRIVATE LIMITED Company

7 hours ago Zaubacorp.com Show details

Enveda Therapeutics India Private Limited's Corporate Identification Number is (CIN) U73100AP2019FTC112638 and its registration number is 112638.Its Email address is [email protected] and its registered address is 502, SRI PRAYAGA RESIDENCY, MYTHREYI NAGAR, PANDURANGAPURAM VISAKHAPATNAM Vishakhapatnam AP 530003 IN , - , .

Category: Contact NumberShow more

Corporate Governance Assertio Therapeutics, Inc.

2 hours ago Investor.assertiotx.com Show details

Corporate Governance. Assertio is committed to conducting its business in accordance with all legal and regulatory requirements and with the highest standards of ethical behavior. To this end, the company has developed a code of conduct to serve as a guide for all company employees and directors to help ensure lawful and ethical conduct.

Category: Contact NumberShow more

Assertio Holdings, Inc. (ASRT) Company Profile & Facts

5 hours ago Finance.yahoo.com Show details

The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in

Category: Contact NumberShow more

Andy Burns Regional Business Director Assertio LinkedIn

6 hours ago Linkedin.com Show details

Assertio. Feb 2018 - Present3 years 8 months. West. • Responsible for recruiting, hiring, training, and leading 9 territory managers representing the West Coast. • Developed a team of top

Title: Regional Business Sales Director
Location: Salt Lake City, Utah, United States
1. 500+ connections

Category: Contact NumberShow more

Assertio Holdings, Inc. Announces 1for4 Reverse Stock Split

9 hours ago Finance.yahoo.com Show details

LAKE FOREST, Ill., May 17, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it has filed a Certificate of Amendment to its

1. Author: Assertio Therapeutics, Inc.

Category: Contact NumberShow more

Assertio Holdings, Inc. Announces 1for4 Reverse Stock Split

6 hours ago Ca.movies.yahoo.com Show details

Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through business development including licensing, mergers, and acquisitions. Investor Contact

Category: Contact NumberShow more

ASRT Insider Trading Assertio Therapeutics Inc Form 4

2 hours ago Secform4.com Show details

Assertio Therapeutics Inc sec form 4 filings insider trading, stock buying and selling.

Category: Contact NumberShow more

Company Assertio Therapeutics News, Employees and Funding

6 hours ago Topionetworks.com Show details

Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines. Assertio currently markets three FDA-approved products and continues to identify, license and develop new products that offer enhanced options for patients that may be underserved by existing therapies.

Category: Contact NumberShow more

Assertio Holdings, Inc. to Participate in Upcoming

8 hours ago Finance.yahoo.com Show details

Assertio Therapeutics, Inc. Investor Contact . Max Nemmers Head, Investor Relations and Administration with at least one main benchmark and a number

Category: Contact NumberShow more

Assertio Therapeutics, Inc. TheStreet

6 hours ago Thestreet.com Show details

Number Of Part-Time Employees: Investors Are Encouraged To Contact The Firm. By PR Newswire. May 8, 2020 10:42 PM EDT Assertio Therapeutics

Category: Contact NumberShow more

Assertio Therapeutics, Inc Portfolio Holdings (13F, 13G)

5 hours ago Fintel.io Show details

Assertio Therapeutics, Inc. The following sets forth the name, present principal occupation or employment, and citizenship of each director and executive officer of Assertio Therapeutics, Inc. The business address of each director and executive officer is c/o Assertio Therapeutics, Inc., 100 South Saunders Road, Suite 300, Lake Forest, Illinois.

Category: Contact NumberShow more

ASSERTIO HOLDINGS, INC. : Shareholders Board Members

2 hours ago Marketscreener.com Show details

Assertio Holdings, Inc. is a specialty pharmaceutical company. The Company owns a portfolio of prescription neurology, inflammation and pain medications. Its marketed products include Cambia (diclofenac potassium) for Oral solution, INDOCIN Oral Suspension, INDOCIN (indomethacin) Suppositories, OXAYDO tablets, SPRIX Nasal Spray, VIVLODEX

Category: Contact NumberShow more

Assertio Holdings Shares Outstanding 20062021 ASRT

3 hours ago Macrotrends.net Show details

Assertio Holdings shares outstanding from 2006 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Category: Contact NumberShow more

Assertio Announces Restructuring Plan and Leadership Changes

4 hours ago Finance.yahoo.com Show details

Assertio has grown through business development including licensing, mergers and acquisitions. Assertio Therapeutics, Inc. Fidelity Investments reported that the number of 401(k

Category: Contact NumberShow more

Assertio Holdings, Inc. to Report Fourth Quarter and Full

1 hours ago Finance.yahoo.com Show details

LAKE FOREST, Ill., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it …

Category: Contact NumberShow more

Assertio Reports First Quarter 2021 Financial Results

1 hours ago Finance.yahoo.com Show details

Assertio’s management will host a conference call to discuss the first quarter 2021 financial results today: Date: Thursday, May 6, 2021. Time: 4:30 p.m. ET. Webcast (live and archive

Category: Contact NumberShow more

ASRT Stock Price Assertio Therapeutics, Inc. Share Price

1 hours ago Groww.in Show details

Get the latest Assertio Therapeutics, Inc. share price or Assertio Therapeutics, Inc. stock price and detailed information including Assertio Therapeutics, Inc. news, historical charts, performance, company statistics and other vital information to help you with your stock investing and trading.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What are the products of assertio therapeutics company?

As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. The company's products include Gralise , Cambia, Lazanda, Zipsor, and DM-1992, which mainly focus on pain, neuropathic pain , and central nervous system diseases.

What is the best way to contact assertio for customer service questions?

To answer patient or healthcare provider questions regarding Assertio products including Customer Service, Product Information or Adverse Event Reporting, contact us at 866.458.6389 or [email protected] com.

What is the name of the company that changed its name to assertio therape?

On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. In 2018, Assertio also moved its headquarters from California to Lake Forest, from Newark, California to Lake Forest, Illinois.

What is the latest news about assertio holdings?

Assertio Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement More News Assertio Holdings, Inc. Announces Adjournment of Annual Meeting of Shareholders Read More

Brand New Updated

Popular Brands

Amazon
Abbvie
Aia
Asml
Att
Amgen
Apple
Adobe
Aptar
Acc
Adidas
Aak
Aes